Cara Therapeutics (CARA) PT Raised to $33 at Jefferies
Tweet
Share
E-mailGet Alerts CARA Hot Sheet
Price: $5.32 --0%
Rating Summary:
6 Buy, 5 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 5 | Down: 13 | New: 23
Rating Summary:
6 Buy, 5 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 5 | Down: 13 | New: 23
Join SI Premium – FREE
Jefferies analyst Chris Howerton raised the price target on Cara Therapeutics (NASDAQ: CARA) to $33.00 (from $25.00) while maintaining a Buy rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Take-Two Interactive (TTWO) PT Raised to $368 at BofA Securities
- Norwegian Cruise (NCLH) PT Raised to $24 at TD Cowen
- Taysha Gene Therapies (TSHA) PT Raised to $14 at BMO Capital on Differentiation
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
Jefferies & CoSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
